C3 - complement component 3 Gene
Also Known as ASP; Plp; HSE-MSF
Species: Mus musculus
Summary
This gene encodes complement protein C3 which plays a central role in the classical, alternative and lectin activation pathways of the Complement System. The encoded preproprotein undergoes a multi-step processing to generate various functional peptides. Mice deficient in the encoded protein fail to clear bacteria from the blood stream upon Infection, display diminished airway hyperresponsiveness and lung eosinophilia upon allergen-induced pulmonary allergy, and develop severe lung injury after deposition of IgG immune complexes. Deficiency of the homolog of the encoded protein in humans was found to be associated with increased susceptibility to infections, age-related macular degeneration, and atypical hemolytic uremic syndrome. [provided by RefSeq, Mar 2015]
C3 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_009778.3 | NP_033908.2 | complement C3 preproprotein |
Gene Ontology
- Molecular Function
- Biological Process
- Cellular Component
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
11728339 | MGI |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in cell surface |
IDA
IDA: Inferred from direct assay
|
25284781 | MGI |
| located in extracellular region |
IDA
IDA: Inferred from direct assay
|
19411110 | MGI |
| located in extracellular space |
IDA
IDA: Inferred from direct assay
|
18292556 | MGI |
| part of protein-containing complex |
IDA
IDA: Inferred from direct assay
|
23487775 | MGI |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
complement C3 |
|
|
Recombinant C3 Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P7863 | Complement C3a Protein, Mouse | P01027-1 (S671-R748) | ≥ 95%, as determined by reducing SDS-PAGE. |
| HY-P78247 | Complement C3 Protein, Mouse (HEK293, His) | P01027-1 (I25-N1663) | ≥ 95%, as determined by reducing SDS-PAGE or Bis-Tris PAGE. |
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-127105 | Iptacopan | Inhibitor | 99.95% | Yes |
| HY-127105A | Iptacopan hydrochloride | Inhibitor | 99.88% | Yes |
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99050 | Sutimlimab | Inhibitor | 98.81% | Unkown |
Clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-14605BS | Rasagiline-13C3 mesylate racemic | Inhibitor | / | Phase 4 |
| HY-P3252A | Pegcetacoplan acetate | Inhibitor | 99.92% | Phase 3 |
| HY-106178 | PMX-53 | Antagonist | 99.95% | Phase 2 |
| HY-P1717A | AMY-101 TFA | Inhibitor | 99.92% | Phase 2 |
| HY-N9481 | Lipoteichoic acid | / | Phase 2 | |
| HY-19903 | ASP-9521 | 98.0% | Phase 2 | |
| HY-124573 | (R)-Odafosfamide | 98.52% | Phase 2 | |
| HY-P3204 | POT-4 | Inhibitor | 98.88% | Phase 2 |
| HY-P2141A | TRV-120027 TFA | Agonist | 99.62% | Phase 2 |
| HY-149040 | Odafosfamide | 99.06% | Phase 2 | |
| HY-156701 | BAY-1128688 | / | Phase 2 | |
| HY-P3204A | POT-4 TFA | Inhibitor | / | Phase 2 |
| HY-P1717 | AMY-101 | Inhibitor | 99.86% | Phase 1 |
| HY-10819 | AG2034 | / | Phase 1 | |
| HY-114913 | Fenarimol | Inhibitor | 99.78% | Phase 1 |
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P990091 | Riliprubart | Inhibitor | 99.90% | Phase 3 |
| HY-P990025 | Empasiprubart | ≥99.0% | Phase 3 | |
| HY-P991022 | Ruxoprubart | Inhibitor | 95.541% | Phase 2 |
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-101502A | SB290157 trifluoroacetate | Antagonist | 99.87% | Unkown |
| HY-12481 | SAR405 | Inhibitor | 99.74% | Unkown |
| HY-N0376 | Liquiritin | 99.99% | Unkown | |
| HY-132295 | Azenosertib | Inhibitor | 99.96% | Unkown |
| HY-Y0479S | L-Lactic acid-13C3 | 99.9% | Unkown | |
| HY-138161 | JR14a | Antagonist | 99.77% | Unkown |
| HY-P1036 | Compstatin | Inhibitor | 99.83% | Unkown |
| HY-15978 | P7C3-A20 | 99.32% | Unkown | |
| HY-W021005 | Silver bis(trifluoromethanesulfonyl)imide | 99.90% | Unkown | |
| HY-P2848 | Cholesterol oxidase, Microorganism | ≥90.0% | Unkown | |
| HY-N0650S | L-Serine-13C3 | 99.95% | Unkown | |
| HY-W015913S | Pyruvic acid-13C3 sodium | Inhibitor | 99.7% | Unkown |
| HY-NP004 | Cobra Venom Factor | Activator | 99.07% | Unkown |
| HY-Y0479AS | L-Lactic acid-13C3 sodium (20% w/w in water) | 99.91% | Unkown | |
| HY-P1717B | AMY-101 acetate | Inhibitor | 99.93% | Unkown |
| HY-103007 | TC-G-1008 | Agonist | 99.36% | Unkown |
| HY-150644 | S07-2010 | 98.35% | Unkown | |
| HY-Y0337S | L-Cysteine-13C3,15N | 99.9% | Unkown | |
| HY-108568 | 15-Deoxy-Δ-12,14-prostaglandin J2 | Agonist | ≥99.0% | Unkown |
| HY-B1659S5 | Glycerol-13C3 | 99.69% | Unkown | |
| HY-P1345A | TLQP-21 TFA | Agonist | 99.90% | Unkown |
| HY-128358 | MR-L2 | Activator | 98.63% | Unkown |
| HY-107379 | AKR1C3-IN-1 | 98.21% | Unkown | |
| HY-134222A | N-Acetylserine | Inhibitor | 98.0% | Unkown |
| HY-15976 | P7C3 | 99.66% | Unkown | |
| HY-P2141 | TRV-120027 | Agonist | 98.21% | Unkown |
| HY-128132 | C3a receptor agonist 1 | Agonist | 98.16% | Unkown |
| HY-112633 | SMN-C3 | Modulator | 99.48% | Unkown |
| HY-133618 | Pomalidomide-C3-adavosertib | 99.84% | Unkown | |
| HY-W004701 | Br-C3-methyl ester | 99.12% | Unkown | |
| HY-161022A | FL118-C3-O-C-amide-C-NH2 formate | 96.49% | Unkown | |
| HY-125877 | PROTAC Mcl1 degrader-1 | Inhibitor | 98.13% | Unkown |
| HY-126521 | N3-C3-NHS ester | 99.85% | Unkown | |
| HY-Y0337S4 | L-Cysteine-13C3 | 99.9% | Unkown | |
| HY-113128S | sn-Glycerol 3-phosphate-13C3 disodium | 98.7% | Unkown | |
| HY-N0650S5 | L-Serine-13C3,15N | 99.9% | Unkown | |
| HY-162266 | C3TD879 | 98.61% | Unkown | |
| HY-40145 | 1-Boc-3-iodoazetidine | 99.79% | Unkown | |
| HY-E70528 | HRV-3C protease fuses with GST | / | Unkown | |
| HY-138557 | AKR1C3-IN-4 | 99.77% | Unkown | |
| HY-P1505A | C3a (70-77) TFA | 99.79% | Unkown | |
| HY-152189 | S19-1035 | 99.93% | Unkown | |
| HY-B1337S4 | Choline Chloride-13C3 | 99.69% | Unkown | |
| HY-140928 | Biotin-PEG4-amino-t-Bu-DADPS-C3-alykne | 95.0% | Unkown | |
| HY-N6978 | Ascr#5 | 98.0% | Unkown | |
| HY-107551 | Hh Pathway-IN-1 | 99.06% | Unkown | |
| HY-117992 | BR103 | 99.66% | Unkown | |
| HY-N4134 | Ciwujianoside C3 | Inhibitor | 99.73% | Unkown |
| HY-145225 | DLin-K-C3-DMA | Chemical | 98.59% | Unkown |
| HY-B0430S | Pantothenic acid-13C3,15N hemicalcium | 99.3% | Unkown | |
| HY-D1581 | BODIPY 505/515-8-C3-COOH | 99.92% | Unkown | |
| HY-W008567 | N-Deschlorobenzoyl indomethacin | 95.0% | Unkown | |
| HY-147090 | Tazemetostat de(methylene morpholine)-O-C3-O-C-COOH | Degrader | 99.06% | Unkown |
| HY-163962 | L18I | 99.89% | Unkown | |
| HY-N0229S8 | L-Alanine-13C3 | 99.90% | Unkown | |
| HY-N10361 | Drupanin | 99.35% | Unkown | |
| HY-RI00407 | hsa-miR-200c-3p inhibitor | 96.28% | Unkown | |
| HY-144432S | D-Pantothenic acid-13C3,15N hemicalcium hemihydrate | 99.7% | Unkown | |
| HY-163032 | FABP4-IN-3 | Inhibitor | 99.64% | Unkown |
| HY-I0400S3 | N-Acetylneuraminic acid-13C-3 | 99.0% | Unkown | |
| HY-100683 | A12B4C3 | Inhibitor | 98.06% | Unkown |
| HY-148142 | Pomalidomide-C3-NHS ester | 98.70% | Unkown | |
| HY-W683760 | N-Nitrosonornicotine | 99.97% | Unkown | |
| HY-B1773AS3 | Sodium propionate-13C3 | 99.45% | Unkown | |
| HY-171544 | AGS-16C3F | 99.81% | Unkown | |
| HY-109154 | Obafistat | Inhibitor | 99.92% | Unkown |
| HY-145127 | ETZ | 99.84% | Unkown | |
| HY-155035 | S07-1066 | 99.48% | Unkown | |
| HY-N0229S10 | L-Alanine-13C3,15N | 98.0% | Unkown | |
| HY-N0680S3 | Thiamine-13C3 hydrochloride | 99.9% | Unkown | |
| HY-N1981S | Triolein-13C3 | Inhibitor | 98.00% | Unkown |
| HY-W004617 | 2,4,6-Tris(4-carboxyphenyl)-1,3,5-triazine | 99.01% | Unkown | |
| HY-W004640 | N-Boc-C1-PEG3-C3-NH2 | 98.0% | Unkown | |
| HY-W007376S | Indole-3-carboxaldehyde-13C | 97.39% | Unkown | |
| HY-40354S | Tofacitinib-13C3 | 99.77% | Unkown | |
| HY-P1036A | Compstatin TFA | Inhibitor | 99.11% | Unkown |
| HY-D1342 | Coumberol | 99.99% | Unkown | |
| HY-R00407 | hsa-miR-200c-3p mimic | 95.41% | Unkown | |
| HY-B0710S | Betaine-13C3 | 99.86% | Unkown | |
| HY-131185 | Pomalidomide-amido-C3-COOH | 99.69% | Unkown | |
| HY-130711B | (S,R,S)-AHPC-C3-NH2 hydrochloride | 96.68% | Unkown | |
| HY-140902A | Biotin-PEG3-C3-NH2 | 97.0% | Unkown | |
| HY-N0322S4 | Cholesterol-13C3 | Agonist | 98.80% | Unkown |
| HY-B0356AS1 | Ciprofloxacin-13C3,15N monohydrochloride | 99.9% | Unkown | |
| HY-W077634 | 3-Amino-5-hydroxybenzoic acid | 99.83% | Unkown | |
| HY-12481A | SAR405 R enantiomer | Control | 99.94% | Unkown |
| HY-130142A | Biotinyl-NH-PEG3-C3-amido-C3-COOH | 99.25% | Unkown | |
| HY-131888 | Pomalidomide-C3-NH2 hydrochloride | 99.72% | Unkown | |
| HY-133479 | Tetrazine-Ph-NHCO-C3-NHS ester | 98.40% | Unkown | |
| HY-152188 | AKR1C3-IN-9 | 99.77% | Unkown | |
| HY-157510 | Thalidomide-O-C3-azide | 98.41% | Unkown | |
| HY-159604 | METTL3-IN-9 | Inhibitor | 95.30% | Unkown |
| HY-172314 | ACHM-025 | 98.06% | Unkown | |
| HY-N0351S | p-Coumaric acid-13C3 | 99.12% | Unkown | |
| HY-N3205 | Neochamaejasmin B | 98.53% | Unkown | |
| HY-W010407S | Cyanuric acid-13C3 | 98.0% | Unkown | |
| HY-W013061S1 | Propane-1,2,3-triyl tripalmitate-13C3 | 98.0% | Unkown | |
| HY-113008AS | cis-Urocanic acid-13C3 | Agonist | 99.46% | Unkown |
| HY-R04629 | hsa-miR-29c-3p mimic | 98.48% | Unkown | |
| HY-W414731 | N-(3-Methylphenyl)anthranilic acid | 99.82% | Unkown | |
| HY-N0650S3 | L-Serine-13C3,15N,d3 | ≥99.90% | Unkown | |
| HY-100196S1 | Pyrroloquinoline quinone-13C3 sodium | 99.29% | Unkown | |
| HY-103608 | (S,R,S)-AHPC-(C3-PEG)2-C6-Cl | 98.85% | Unkown | |
| HY-108568S | 15-Deoxy-Δ-12,14-prostaglandin J2-d4 | Agonist | 98.10% | Unkown |
| HY-128856 | P7C3-OMe | 98.26% | Unkown | |
| HY-133584 | Bis-SS-C3-NHS ester | 98.0% | Unkown | |
| HY-15129S | O-Phospho-L-serine-13C3,15N | Modulator | 99.19% | Unkown |
| HY-158118 | Lys(CO-C3-p-I-Ph)-OMe | 97.19% | Unkown | |
| HY-160897 | Methoxy-PEG2000-C3-amide-C2-Mal | 99.69% | Unkown | |
| HY-161022S1 | FL118-C3-O-C-amide-C-NH2-d5 formate | / | Unkown | |
| HY-162816 | PROTAC HPK1 Degrader-3 | / | Unkown | |
| HY-163940 | LX1 | 99.13% | Unkown | |
| HY-N0136S1 | (±)-Taxifolin-13C3 | Inhibitor | 99.63% | Unkown |
| HY-N0230S | β-Alanine-13C3,15N | 99.99% | Unkown | |
| HY-N0898S | Catechin-13C3 | 98.06% | Unkown | |
| HY-N7404S1 | Nε,Nε,Nε-Trimethyllysine-13C3 chloride | 98.0% | Unkown | |
| HY-P1640 | (Trp63,Trp64)-C3a(63-77) | Agonist | 99.23% | Unkown |
| HY-R00006 | hsa-let-7c-3p mimic | 93.63% | Unkown | |
| HY-R00717 | hsa-miR-34c-3p mimic | 94.18% | Unkown | |
| HY-R01568 | hsa-miR-518c-3p mimic | 92.33% | Unkown | |
| HY-R01678 | hsa-miR-548c-3p mimic | 92.16% | Unkown | |
| HY-W442078 | Iodine-C3-O-C3-PEG-Boc | ≥98.0% | Unkown | |
| HY-113294S | 3-Hydroxykynurenine-13C3,15N | Inducer | 99.0% | Unkown |
| HY-171115 | Pyrone-211 | 99.32% | Unkown | |
| HY-403561 | 2-MSP-C3-NHS ester | / | Unkown | |
| HY-W1120221 | Lenalidomide-C3-NH2 | / | Unkown | |
| HY-W336094 | 1,3-Glyceryl dilinoleate | / | Unkown | |
| HY-115560A | Thalidomide-O-amido-C3-NH2 TFA | Inducer | 99.58% | Unkown |
| HY-131646 | Thalidomide-O-amido-C3-PEG3-C1-NH2 | Inducer | 99.08% | Unkown |
| HY-N1428S3 | Citric acid-13C3 | Inhibitor | 98% | Unkown |
| HY-103612 | Thalidomide-O-amido-C3-COOH | Inducer | 98.43% | Unkown |
| HY-111297 | BMVC4 | / | Unkown | |
| HY-116170 | SN34037 | Inhibitor | 99.02% | Unkown |
| HY-120903 | DBCO-C3-Acid | 99.68% | Unkown | |
| HY-131455A | Biotin-C1-PEG3-C3-amido-C5-Gly-Arg-Gly-N3 TFA | 98.0% | Unkown | |
| HY-135306 | Cl-C6-PEG4-C3-COOH | 99.65% | Unkown | |
| HY-138847A | Thalidomide-4-O-C3-NH2 hydrochloride | Inducer | / | Unkown |
| HY-140808 | Azido-PEG3-C3-OH | 98.0% | Unkown | |
| HY-140841 | APN-C3-PEG4-azide | 97.97% | Unkown | |
| HY-148608 | LysoPalloT-NH-amide-C3-ph-m-O-C11 | Agonist | / | Unkown |
| HY-158122 | Lys(CO-C3-p-I-Ph)-O-tBu | 98.14% | Unkown | |
| HY-161022 | FL118-C3-O-C-amide-C-NH2 | / | Unkown | |
| HY-161022S | FL118-C3-O-C-amide-C-NH2-d5 | / | Unkown | |
| HY-161708 | PROTAC FLT3/CDKs degrader-1 | Degrader | / | Unkown |
| HY-163678 | Pomalidomide-CO-C7-NH-CO-C3-COOH | 98.55% | Unkown | |
| HY-176084 | RJG-2051 | 99.42% | Unkown | |
| HY-B0150S1 | Nicotinamide-15N,13C3 | Inhibitor | 98.88% | Unkown |
| HY-B0234S | Estrone-13C3 | Agonist | 98.0% | Unkown |
| HY-B0389S9 | D-Glucose-13C3-2 | 98% | Unkown | |
| HY-B0495S | Lamotrigine-13C3,d3 | 97.46% | Unkown | |
| HY-B0891S1 | 17α-Hydroxyprogesterone-13C3 | Agonist | 98.9% | Unkown |
| HY-B1804S | Tricaprilin-13C3 | 98.0% | Unkown | |
| HY-D1056A5 | Lipopolysaccharides, from E. coli K-235 | Activator | / | Unkown |
| HY-N0172S | Caffeic acid-13C3 | Inhibitor | / | Unkown |
| HY-N0437S2 | Progesterone-13C3 | Agonist | 99.60% | Unkown |
| HY-N0464S | Quinic acid-13C3 | Inhibitor | 99.5% | Unkown |
| HY-N0610AS2 | Cinnamic acid-13C3 | 99.91% | Unkown | |
| HY-N0771S6 | L-Cysteine-13C3,15N,d3 | 99.6% | Unkown | |
| HY-N2041S4 | Myristic acid-13C3 | 99.9% | Unkown | |
| HY-N2362S1 | DL-Alanine-13C-3 | 98.0% | Unkown | |
| HY-P1398 | Compstatin control peptide | Control | 99.95% | Unkown |
| HY-P1505 | C3a (70-77) | / | Unkown | |
| HY-P2325 | Exoenzyme C3, clostridium botulinum | Inhibitor | / | Unkown |
| HY-R00333 | hsa-miR-181c-3p mimic | 94.69% | Unkown | |
| HY-R00407A | hsa-miR-200c-3p agomir | / | Unkown | |
| HY-R00840 | hsa-miR-376c-3p mimic | 93.13% | Unkown | |
| HY-R01112 | hsa-miR-449c-3p mimic | 99.11% | Unkown | |
| HY-R02698 | mmu-miR-181c-3p mimic | 99.43% | Unkown | |
| HY-R02897 | mmu-miR-302c-3p mimic | 98.79% | Unkown | |
| HY-RI00333 | hsa-miR-181c-3p inhibitor | 99.68% | Unkown | |
| HY-RI00840 | hsa-miR-376c-3p inhibitor | 99.33% | Unkown | |
| HY-RS01743 | C3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS10521 | Pik3c3 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W010421S | Ammelide-13C3 | 99.85% | Unkown | |
| HY-W024692 | Indomethacin methylester | 99.92% | Unkown | |
| HY-W099927 | [C3MPr]NTf2 | 97.0% | Unkown | |
| HY-W654331 | Quinolinic acid-13C3, 15N | 99.76% | Unkown | |
| HY-Y1117S2 | Melamine-15N3,13C3 | 96.08% | Unkown | |
| HY-Y1662 | D-Aminoacylase | / | Unkown | |
| HY-131800A | 3'-NH2-ATP tetrasodium, 100 mM Solution | 98.70% | Unkown | |
| HY-158861 | C3-K2-E14 | 98.5% | Unkown | |
| HY-160773A | DBCO-C3-amide-PEG6-NHS ester | 95.20% | Unkown | |
| HY-19903R | ASP-9521 (Standard) | 94.47% | Unkown | |
| HY-43193 | Cl-C6-PEG3-C3-acid | ≥97.0% | Unkown | |
| HY-RI04616 | hsa-miR-29c-3p inhibitor | 97.78% | Unkown | |
| HY-RS21501 | C3ar1 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W046063 | O-Phthalimide-C3-acid | / | Unkown | |
| HY-W069545 | (S)-1-Tetralol | 99.75% | Unkown | |
| HY-W112031 | OH-PEG2-C3-NH2 | ≥95.0% | Unkown | |
| HY-W392808 | Spacer phosphoramidite C3 | 98.0% | Unkown | |
| HY-W422359A | 2-Aminopurine-O-Ph-NHCO-C3-COOH hydrochloride | 95.27% | Unkown | |
| HY-W590573 | C3 Ceramide | 98.49% | Unkown | |
| HY-W686763 | Triacetylphloroglucinol | 99.95% | Unkown | |
| HY-W747332 | Pyruvic aldehyde-13C3 (20% in water) | 95.0% | Unkown | |
| HY-W769017 | Thiothiamine-13C3 | / | Unkown | |
| HY-W018171S2 | 3,5,6-Trichloro-2-pyridinol-13C3 | / | Unkown | |
| HY-18085S2 | Quercetin-13C3 | / | Unkown | |
| HY-115560 | Thalidomide-O-amido-C3-NH2 | Inducer | / | Unkown |
| HY-116084S1 | Trimethylamine-N-oxide-13C3 | Activator | / | Unkown |
| HY-130711A | (S,R,S)-AHPC-C3-NH2 TFA | / | Unkown | |
| HY-131876 | Thalidomide-O-C3-acid | Inducer | / | Unkown |
| HY-135900 | Aniline-MPB-amino-C3-PBD | Inhibitor | / | Unkown |
| HY-15097S | Myricetin-13C3 | Inducer | / | Unkown |
| HY-B0412S3 | Estriol-13C3 | Antagonist | / | Unkown |
| HY-130711 | (S,R,S)-AHPC-C3-NH2 | / | Unkown | |
| HY-131186 | Pomalidomide-amido-C3-piperazine-N-Boc | / | Unkown | |
| HY-105414 | Esterbut-3 | / | Unkown | |
| HY-105969 | Dichloromethotrexate | / | Unkown | |
| HY-111843 | Ch55-O-C3-NH2 | / | Unkown | |
| HY-113008S1 | Urocanic acid-13C3 | / | Unkown | |
| HY-113357S | m-Coumaric acid-13C3 | / | Unkown | |
| HY-114773 | N-Undecanoyl-L-homoserine lactone | / | Unkown | |
| HY-115902 | FGFR4-IN-7 | / | Unkown | |
| HY-116021S | Buquinolate-13C3 | Inhibitor | / | Unkown |
| HY-116025 | APN-C3-PEG4-alkyne | / | Unkown | |
| HY-116295 | MRS2690 | / | Unkown | |
| HY-116295A | MRS2690 disodium | / | Unkown | |
| HY-121656 | AKR1C2/3-IN-2 | Inhibitor | / | Unkown |
| HY-12210 | (S)-BI-1001 | Inhibitor | / | Unkown |
| HY-12216S | Resmetirom-13C3,15N | Agonist | / | Unkown |
| HY-122888 | MPT0L145 | / | Unkown | |
| HY-123732 | CRT0083914 | / | Unkown | |
| HY-124456 | Unguinol | Inhibitor | / | Unkown |
| HY-12542S | Dantrolene-13C3 | Inhibitor | 99.0% | Unkown |
| HY-126287 | JND4135 | / | Unkown | |
| HY-127105B | Iptacopan TFA | Inhibitor | / | Unkown |
| HY-128748S4 | DL-Glyceraldehyde-13C3 | / | Unkown | |
| HY-128753S4 | D-Lyxose-13C-3 | / | Unkown | |
| HY-130142 | Biotinyl-NH-PEG3-C3-amido-C3-COOH (DIPEA) | / | Unkown | |
| HY-130585S | Estradiol undecylate-13C3 | / | Unkown | |
| HY-130711C | (S,R,S)-AHPC-C3-NH2 dihydrochloride | / | Unkown | |
| HY-131184 | N-Boc-piperazine-C3-COOH | / | Unkown | |
| HY-131190 | N-Boc-SBP-0636457-O-C3-COOH | / | Unkown | |
| HY-131606S | Cidofovir diphosphate-13C3 | Inhibitor | / | Unkown |
| HY-131801A | 3'-NH2-GTP tetrasodium | / | Unkown | |
| HY-131888A | Pomalidomide-C3-NH2 | / | Unkown | |
| HY-133403A | Biotin-C1-PEG3-C3-amine TFA | / | Unkown | |
| HY-133585 | Bis-SS-C3-sulfo-NHS ester | / | Unkown | |
| HY-133702 | Aniline-piperazine-C3-NH-Boc | / | Unkown | |
| HY-134679 | N-Boc-C1-PEG5-C3-NH2 | / | Unkown | |
| HY-134692 | Azido-C1-PEG3-C3-NH2 | / | Unkown | |
| HY-134693 | Azido-C1-PEG4-C3-NH2 | / | Unkown | |
| HY-134749 | Propargyl-PEG2-urea-C3-triethoxysilane | / | Unkown | |
| HY-135901 | Py-MPB-amino-C3-PBD | Inhibitor | / | Unkown |
| HY-13599S3 | Cladribine-13C3,15N3 | / | Unkown | |
| HY-13632S1 | Exemestane-13C3 | Inhibitor | / | Unkown |
| HY-136457S | 2-NP-AHD-13C3 | / | Unkown | |
| HY-137842 | L-Alanine-2-naphthylamide | Substrate | / | Unkown |
| HY-138847 | Thalidomide-O-C3-NH2 | Inducer | / | Unkown |
| HY-138850 | Thalidomide-NH-amido-C3-NH2 | Inducer | / | Unkown |
| HY-138850A | Thalidomide-NH-amido-C3-NH2 hydrochloride | Inducer | / | Unkown |
| HY-139145S | Etbicyphat-13C3 | / | Unkown | |
| HY-139427S | 3-Methylglutaconic acid-13C3 | / | Unkown | |
| HY-139545 | Thalidomide-4-C3-NH2 hydrochloride | Inducer | / | Unkown |
| HY-139721 | Tenofovir-C3-O-C15-CF3 ammonium | Inhibitor | / | Unkown |
| HY-139722 | Tenofovir-C3-O-C12-trimethylsilylacetylene ammonium | Inhibitor | / | Unkown |
| HY-140019 | Azido-PEG3-amide-C3-triethoxysilane | / | Unkown | |
| HY-140288 | DBCO-C3-PEG4-amine | / | Unkown | |
| HY-140295 | DBCO-C3-PEG4-NH-Boc | / | Unkown | |
| HY-140347 | APN-C3-NH-Boc | / | Unkown | |
| HY-140478 | Boc-NH-PEG4-C3-acid | / | Unkown | |
| HY-140902 | rel-Biotin-PEG3-C3-NH2 | / | Unkown | |
| HY-140927 | Azido-C3-UV-biotin | / | Unkown | |
| HY-141065 | N-(azide-PEG3)-N'-(Amine-C3-Amide-PEG4)-Cy5 | / | Unkown | |
| HY-141407 | m-PEG3-amido-C3-triethoxysilane | / | Unkown | |
| HY-141597 | Acid-C3-SSPy | / | Unkown | |
| HY-141651 | (S,R,S)-AHPC-C3-COOH | / | Unkown | |
| HY-141857S | 5-(4-Hydroxyphenyl)-5-phenyl-d5-hydantoin-2,4,5-13C3 | / | Unkown | |
| HY-141893 | 3-Cyanovinylcarbazole phosphoramidite | Inhibitor | / | Unkown |
| HY-141901S2 | Dehydroepiandrosterone-13C3 | / | Unkown | |
| HY-141907S | 17β-Estradiol-13C3 | 98.1% | Unkown | |
| HY-142140S | 3-epi-25-Hydroxy Vitamin D3-d6 | / | Unkown | |
| HY-143342 | LEB-03-144 | / | Unkown | |
| HY-143400 | HSP70-IN-3 | Inhibitor | / | Unkown |
| HY-143439 | LX-039 | Antagonist | / | Unkown |
| HY-143687S | 3-Cyano Gimeracil methyl ether-13C3 | / | Unkown | |
| HY-144749 | AKR1C3-IN-5 | / | Unkown | |
| HY-145253 | Tri(TLR4-IN-C34-C2-amide-PEG1)-amide-C3-COOH | Inhibitor | / | Unkown |
| HY-145254 | Tri(TLR4-IN-C34-PEG2-amide-PEG1)-amide-C3-COOH | Inhibitor | / | Unkown |
| HY-145255 | Tri(TLR4-IN-C34-C2-amide-C3-amide-PEG1)-amide-C3-COOH | Inhibitor | / | Unkown |
| HY-14605S | Rasagiline-13C3 mesylate | / | Unkown | |
| HY-146573 | AKR1C3-IN-6 | / | Unkown | |
| HY-146574 | AKR1C3-IN-7 | / | Unkown | |
| HY-146575 | AKR1C3-IN-8 | / | Unkown | |
| HY-148471A | C3-Amide-C4-NH2 | / | Unkown | |
| HY-148515 | (S,R)-AHPC-O-C3-O-COOH | / | Unkown | |
| HY-149560 | Thalidomide-5-O-C3-NH2 hydrochloride | Inducer | 99.08% | Unkown |
| HY-150624 | SARS-CoV-2 nsp13-IN-3 | Inhibitor | / | Unkown |
| HY-150646 | S07-2009 | / | Unkown | |
| HY-150648 | S07-2008 | / | Unkown | |
| HY-150649 | S07-2005 (racemic) | / | Unkown | |
| HY-150650 | S07-2001 | / | Unkown | |
| HY-150658S2 | DMT-2′O-TBDMS-rA(ac) phosphoramidite-13C3 | / | Unkown | |
| HY-151997S | 1,2-Dioleoyl-3-lauroyl-rac-glycerol-13C3 | / | Unkown | |
| HY-153456 | Hedgehog IN-2 | Inhibitor | / | Unkown |
| HY-153539 | AP-C3 | Inhibitor | / | Unkown |
| HY-153540 | AP-C4 | Inhibitor | / | Unkown |
| HY-15398S1 | Vitamin D3-13C3 | Activator | / | Unkown |
| HY-155259 | Pomalidomide-5-C3-NH2 hydrochloride | 96.02% | Unkown | |
| HY-155502 | AKR1C3-IN-10 | / | Unkown | |
| HY-155716 | G43-C3-TEG | Inhibitor | / | Unkown |
| HY-157541S | 2-Chloro-1,3-propanediol-13C3 | / | Unkown | |
| HY-157810 | AKR1C3-IN-11 | / | Unkown | |
| HY-158383 | Pomalidomide-CO-C3-PEG4-C6-NH2 | / | Unkown | |
| HY-158732 | MAO-B-IN-33 | Inhibitor | / | Unkown |
| HY-158994S | MEGDSRGG-(Ala-13C3,15N)-GGEA-(Leu-13C6,15N)-DPESAASSLSGAS TFA | / | Unkown | |
| HY-15977 | (S)-P7C3-OMe | / | Unkown | |
| HY-161131 | Lenalidomide 4'-alkyl-C3-azide | / | Unkown | |
| HY-161468 | Thalidomide-N-C3-O-C4-O-C3-OH | Inducer | / | Unkown |
| HY-161653 | Boc-NH-C3-O-Ph(NO2)-methylester-O-pyrrolidine-2,5-dione | / | Unkown | |
| HY-161832 | (S,R,S)-Me-AHPC-amide-C3-alkyne | / | Unkown | |
| HY-161839 | AKR1C2/3-IN-1 | / | Unkown | |
| HY-162714 | C3N-Dbn-Trp2 | Inhibitor | / | Unkown |
| HY-163223 | (S,R,S)-AHPC-CO-CH2-piperazine-C3-piperazine-Boc | / | Unkown | |
| HY-163323 | AKR1C3-IN-12 | / | Unkown | |
| HY-163609 | PROTAC AKR1C3 degrader-1 | / | Unkown | |
| HY-163610 | AKR1C3-IN-13 | / | Unkown | |
| HY-163758 | COOH-C3-CONH-C7-COOH | / | Unkown | |
| HY-163784 | AKR1C3-IN-14 | / | Unkown | |
| HY-163821 | HO-CONH-C3-PEG3-NH2 | / | Unkown | |
| HY-163903 | OH-C2-PEG3-NHCO-C3-COOH | / | Unkown | |
| HY-163904 | (S,R,R)-VH032-CO-C3-CONH-C2-PEG3-OH | / | Unkown | |
| HY-163964 | Lenalidomide-C3-PEG3-N3 | / | Unkown | |
| HY-164085 | Azide-C3-NHCO-C3-NHS ester | / | Unkown | |
| HY-164909 | PZ-3022 | / | Unkown | |
| HY-168239 | Thalidomide-piperidine-CO-piperazine-C-3-Br-Ph | / | Unkown | |
| HY-169401 | L321-NH-C3-PEG3-C1-NH2 | / | Unkown | |
| HY-170531 | SR 142948-C3-NHMe | / | Unkown | |
| HY-170808 | PROTAC BRD4 Degrader-28 | Degrader | / | Unkown |
| HY-170867 | Nrf2/HO-1 activator 3 | / | Unkown | |
| HY-170978 | PROTAC CDK9 degrader-11 | Degrader | / | Unkown |
| HY-172804 | SDH-IN-26 | / | Unkown | |
| HY-173132 | AKR1Cs-IN-1 | / | Unkown | |
| HY-173453 | AKR1C3-IN-15 | / | Unkown | |
| HY-173500 | MG-3C | / | Unkown | |
| HY-174384 | MET Transcription-IN-1 | / | Unkown | |
| HY-17461S | Cortisone-13C3 | Agonist | / | Unkown |
| HY-175074 | C3 BODIPY Ganglioside GM1 (d18:1/3:0) ammonium | / | Unkown | |
| HY-175193 | N-Deshydroxyethyl Dasatinib-C3-NH2 | Inhibitor | / | Unkown |
| HY-175754 | C3TD078 | Inhibitor | / | Unkown |
| HY-175936 | NH2-C3-piperazin-Pip-Boc | / | Unkown | |
| HY-176037 | Boc-C3-amide-C10-amine | / | Unkown | |
| HY-176243 | 15-Deoxy-Δ12,14-Prostaglandin J2-2-glyceryl ester | Agonist | / | Unkown |
| HY-176335 | TBK1 ligand 2-C-O-C4-O-C3-O-C-amide | Inhibitor | / | Unkown |
| HY-176363 | Adavosertib-C3-NH-Boc | Inhibitor | / | Unkown |
| HY-176364 | AZD9496-O-C3-O-C3-O-C-acid | Inhibitor | / | Unkown |
| HY-176385 | 3-Fluoro-desmethyl-cabozantinib-C3-O-C3-PEG-acid | Ligand | / | Unkown |
| HY-176978 | (S,S,S)-Me-AHPC-amide-C3-alkyne | / | Unkown | |
| HY-177148 | G256 | Substrate | / | Unkown |
| HY-177148A | G256 dihydrochloride | Substrate | / | Unkown |
| HY-177621 | Cevolisiran | Inhibitor | / | Unkown |
| HY-177621A | Cevolisiran sodium | Inhibitor | / | Unkown |
| HY-177802 | C3 sodium | Inhibitor | / | Unkown |
| HY-178284 | Factor B-IN-7 | Inhibitor | / | Unkown |
| HY-178299S | 3-Amino-5-hydroxybenzoic acid-13C | / | Unkown | |
| HY-179170S | Malonyl CoA-13C3 lithium | Inhibitor | / | Unkown |
| HY-179863 | BODIPY 505/515-C3-CONH-Oleic acid | / | Unkown | |
| HY-180562 | KARS-IN-1 | Inhibitor | / | Unkown |
| HY-180971 | Ceritinib-amide-C3-acid | Ligand | / | Unkown |
| HY-180978 | H2N-PEG3-C2-Trizole-C3-COOH | / | Unkown | |
| HY-180980 | H2N-PEG4-C2-Trizole-C3-COOH | / | Unkown | |
| HY-181040 | Factor B-IN-8 | Inhibitor | / | Unkown |
| HY-181062 | VWK147 | / | Unkown | |
| HY-181146 | MK-7762 | Inhibitor | / | Unkown |
| HY-181542 | SG-55 | / | Unkown | |
| HY-181918 | PLM-101-C3-NHBoc | / | Unkown | |
| HY-182978 | Pomalidomide-C3-O-C4-O-C3-NH2 | / | Unkown | |
| HY-183352 | BuChE-IN-23 | Inhibitor | / | Unkown |
| HY-184526 | HOOC-PEG5-N-(C3H7-isopropyl)-NH2 | / | Unkown | |
| HY-184537 | Desmethyl-QCA276-C3-alkyne | / | Unkown | |
| HY-184699 | AKR1C3-IN-16 | Inhibitor | / | Unkown |
| HY-186105 | P7C3-S243 | / | Unkown | |
| HY-186105A | (-)-P7C3-S243 | Inhibitor | / | Unkown |
| HY-187077 | UNC0642-C3-COOH | Ligand | / | Unkown |
| HY-19657S1 | Oxypurinol-13C3,15N3 | Inhibitor | / | Unkown |
| HY-19717S | DCVC-13C3,15N | / | Unkown | |
| HY-200854 | Iptacopan hydrochloride hydrate | Inhibitor | / | Unkown |
| HY-21191S | Perfluorobutanesulfonic acid-13C3 sodium | / | Unkown | |
| HY-21196S | Perfluorohexanesulfonic acid-13C3 sodium | / | Unkown | |
| HY-23506S | 1-Aminohydantoin-13C3 | / | Unkown | |
| HY-32349S3 | Ercalcidiol-13C3 | / | Unkown | |
| HY-32351B | 3-epi-Calcifediol | / | Unkown | |
| HY-40354S1 | Tofacitinib-13C3,15N | 99.57% | Unkown | |
| HY-42429 | CPI-203-PEG1-C3-O-COOH | / | Unkown | |
| HY-A0090S | Nitrofurantoin-13C3 | Inhibitor | / | Unkown |
| HY-A0132S5 | N-Acetyl-D-glucosamine-13C-3 | / | Unkown | |
| HY-A0132S9 | N-Acetyl-D-glucosamine-13C3,15N | / | Unkown | |
| HY-A0253S | Cefacetrile-13C3 | / | Unkown | |
| HY-B0143S4 | Niacin-15N,13C3 | / | Unkown | |
| HY-B0166S4 | L-Ascorbic acid-13C-3 | / | Unkown | |
| HY-B0388S | Probucol-13C3 | Inhibitor | / | Unkown |
| HY-B0389S18 | D-Glucose-13C3-1 | / | Unkown | |
| HY-B0495S4 | Lamotrigine-13C3 | / | Unkown | |
| HY-B0526S | Flumequine-13C3 | Inhibitor | / | Unkown |
| HY-B0636S1 | Triamcinolone acetonide-13C3 | / | Unkown | |
| HY-B1075AS | (Rac)-Fosfomycin (benzylamine)-13C3 | / | Unkown | |
| HY-B1331S1 | Cyromazine-13C3 | / | Unkown | |
| HY-B1449S4 | Uridine-13C-3 | / | Unkown | |
| HY-B1659AS | D-Glycerol-13C-3 | / | Unkown | |
| HY-B1659S | Glycerol-13C3,d8 | / | Unkown | |
| HY-B1890S | (±)-Catechin-13C3 | Inhibitor | / | Unkown |
| HY-B2235S | (Z,Z)-Lecithin-13C3 | / | Unkown | |
| HY-CE00612 | 2'-(5''-Phosphoribosyl)-3'-dephospho-CoA | / | Unkown | |
| HY-CE00614 | 2'-(5-Triphosphoribosyl)-3'-dephospho-CoA | / | Unkown | |
| HY-D1516 | NerveGreen C3 | / | Unkown | |
| HY-D1558 | 1,3,5,7-Tetramethyl-2,6-diiodo-C3-SE-BODIPYs | / | Unkown | |
| HY-D2200 | Cy5.5(Me)-C3-DBCO | / | Unkown | |
| HY-D3516 | 5-FAM C3 alkyne | / | Unkown | |
| HY-D3518 | Coumarin 343 C3 azide | / | Unkown | |
| HY-E70152 | ST6 Sialyltransferase 4 | / | Unkown | |
| HY-E71077 | (5R)-Carbapenem-3-carboxylate synthase | / | Unkown | |
| HY-N0001S | (±)-Epicatechin-13C3 | / | Unkown | |
| HY-N0055S | Chlorogenic acid-13C3 | / | Unkown | |
| HY-N0059S3 | D-Arabinose-13C-3 | / | Unkown | |
| HY-N0060S1 | Ferulic acid-13C3 | Inhibitor | 98.3% | Unkown |
| HY-N0086S3 | N6-Methyladenosine-13C3 | Inhibitor | / | Unkown |
| HY-N0210S2 | D-Galactose-13C-3 | 99.80% | Unkown | |
| HY-N0229S5 | L-Alanine-13C3,15N,d4 | 99.7% | Unkown | |
| HY-N0376R | Liquiritin (Standard) | / | Unkown | |
| HY-N0379S8 | D-Mannose-13C-3 | / | Unkown | |
| HY-N0382S | Galangin-13C3 | / | Unkown | |
| HY-N0521AS | (+)-Gallocatechin-13C3 | / | Unkown | |
| HY-N0683S1 | 2-ambo-Vitamin E-13C3 | Inhibitor | / | Unkown |
| HY-N10263 | Palmarumycin C3 | / | Unkown | |
| HY-N10519 | Cellooctaose | / | Unkown | |
| HY-N10998 | Chamaejasmenin A | / | Unkown | |
| HY-N11646 | Ganorbiformin B | Inhibitor | / | Unkown |
| HY-N1480S3 | (-)-Fucose-13C-3 | / | Unkown | |
| HY-N19814 | 3'-Deacetylfusicoccin A | / | Unkown | |
| HY-N1981S2 | Triolein-13C3-1 | / | Unkown | |
| HY-N2362S7 | DL-Alanine-13C3-4 | / | Unkown | |
| HY-N8847S | α-Ionone-13C3 | / | Unkown | |
| HY-P1142S | GLP-2(rat) (Ala-13C3,15N) | / | Unkown | |
| HY-P1142S1 | GLP-2(rat) (Ala-13C3,15N) TFA | / | Unkown | |
| HY-P11699 | AAPDNRETF | / | Unkown | |
| HY-P11857 | Alkyne-GRWHPM-CONH-NH-CMK | Inhibitor | / | Unkown |
| HY-P11946 | C3.15 | / | Unkown | |
| HY-P1345 | TLQP-21 | Agonist | / | Unkown |
| HY-P1345B | [DArg10, DAla20] TLQP-21 | / | Unkown | |
| HY-P1345C | [DArg10, Aib20] TLQP-21 | Antagonist | / | Unkown |
| HY-P1363S1 | β-Amyloid (1-42), human, Ala(13C3,15N) TFA | 99.57% | Unkown | |
| HY-P1398A | Compstatin control peptide TFA | Control | / | Unkown |
| HY-P2830 | Complement factor D | / | Unkown | |
| HY-P5071 | EcAMP3 | / | Unkown | |
| HY-R00006A | hsa-let-7c-3p agomir | / | Unkown | |
| HY-R00333A | hsa-miR-181c-3p agomir | / | Unkown | |
| HY-R00717A | hsa-miR-34c-3p agomir | / | Unkown | |
| HY-R00832 | hsa-miR-374c-3p mimic | / | Unkown | |
| HY-R00832A | hsa-miR-374c-3p agomir | / | Unkown | |
| HY-R00840A | hsa-miR-376c-3p agomir | / | Unkown | |
| HY-R01112A | hsa-miR-449c-3p agomir | / | Unkown | |
| HY-R01546 | hsa-miR-513c-3p mimic | / | Unkown | |
| HY-R01546A | hsa-miR-513c-3p agomir | / | Unkown | |
| HY-R01568A | hsa-miR-518c-3p agomir | / | Unkown | |
| HY-R01590 | hsa-miR-519c-3p mimic | / | Unkown | |
| HY-R01590A | hsa-miR-519c-3p agomir | / | Unkown | |
| HY-R01598 | hsa-miR-520c-3p mimic | / | Unkown | |
| HY-R01598A | hsa-miR-520c-3p agomir | / | Unkown | |
| HY-R01678A | hsa-miR-548c-3p agomir | / | Unkown | |
| HY-R02506 | hsa-miR-892c-3p mimic | / | Unkown | |
| HY-R02506A | hsa-miR-892c-3p agomir | / | Unkown | |
| HY-R02698A | mmu-miR-181c-3p agomir | / | Unkown | |
| HY-R02795 | mmu-miR-1970c-3p mimic | / | Unkown | |
| HY-R02795A | mmu-miR-1970c-3p agomir | / | Unkown | |
| HY-R02833 | mmu-miR-216c-3p mimic | / | Unkown | |
| HY-R02833A | mmu-miR-216c-3p agomir | / | Unkown | |
| HY-R02840 | mmu-miR-219c-3p mimic | / | Unkown | |
| HY-R02840A | mmu-miR-219c-3p agomir | / | Unkown | |
| HY-R02897A | mmu-miR-302c-3p agomir | / | Unkown | |
| HY-R03043 | mmu-miR-344c-3p mimic | / | Unkown | |
| HY-R03043A | mmu-miR-344c-3p agomir | / | Unkown | |
| HY-R03077 | mmu-miR-34c-3p mimic | / | Unkown | |
| HY-R03077A | mmu-miR-34c-3p agomir | / | Unkown | |
| HY-R03104 | mmu-miR-374c-3p mimic | / | Unkown | |
| HY-R03104A | mmu-miR-374c-3p agomir | / | Unkown | |
| HY-R03111 | mmu-miR-376c-3p mimic | / | Unkown | |
| HY-R03111A | mmu-miR-376c-3p agomir | / | Unkown | |
| HY-R03148 | mmu-miR-449c-3p mimic | / | Unkown | |
| HY-R03148A | mmu-miR-449c-3p agomir | / | Unkown | |
| HY-R03198 | mmu-miR-467c-3p mimic | / | Unkown | |
| HY-R03198A | mmu-miR-467c-3p agomir | / | Unkown | |
| HY-R03460 | mmu-miR-669c-3p mimic | / | Unkown | |
| HY-R03460A | mmu-miR-669c-3p agomir | / | Unkown | |
| HY-R04277 | rno-miR-196c-3p mimic | / | Unkown | |
| HY-R04277A | rno-miR-196c-3p agomir | / | Unkown | |
| HY-R04284 | rno-miR-200c-3p mimic | / | Unkown | |
| HY-R04284A | rno-miR-200c-3p agomir | / | Unkown | |
| HY-R04468 | rno-miR-449c-3p mimic | / | Unkown | |
| HY-R04468A | rno-miR-449c-3p agomir | / | Unkown | |
| HY-R04484 | rno-miR-466c-3p mimic | / | Unkown | |
| HY-R04484A | rno-miR-466c-3p agomir | / | Unkown | |
| HY-RI00006 | hsa-let-7c-3p inhibitor | / | Unkown | |
| HY-RI00006A | hsa-let-7c-3p antagomir | / | Unkown | |
| HY-RI00333A | hsa-miR-181c-3p antagomir | / | Unkown | |
| HY-RI00407A | hsa-miR-200c-3p antagomir | / | Unkown | |
| HY-RI00717 | hsa-miR-34c-3p inhibitor | / | Unkown | |
| HY-RI00717A | hsa-miR-34c-3p antagomir | / | Unkown | |
| HY-RI00832 | hsa-miR-374c-3p inhibitor | / | Unkown | |
| HY-RI00832A | hsa-miR-374c-3p antagomir | / | Unkown | |
| HY-RI00840A | hsa-miR-376c-3p antagomir | / | Unkown | |
| HY-RI01112 | hsa-miR-449c-3p inhibitor | / | Unkown | |
| HY-RI01112A | hsa-miR-449c-3p antagomir | / | Unkown | |
| HY-RI01546 | hsa-miR-513c-3p inhibitor | / | Unkown | |
| HY-RI01546A | hsa-miR-513c-3p antagomir | / | Unkown | |
| HY-RI01568 | hsa-miR-518c-3p inhibitor | / | Unkown | |
| HY-RI01568A | hsa-miR-518c-3p antagomir | / | Unkown | |
| HY-RI01590 | hsa-miR-519c-3p inhibitor | / | Unkown | |
| HY-RI01590A | hsa-miR-519c-3p antagomir | / | Unkown | |
| HY-RI01598 | hsa-miR-520c-3p inhibitor | / | Unkown | |
| HY-RI01598A | hsa-miR-520c-3p antagomir | / | Unkown | |
| HY-RI01678 | hsa-miR-548c-3p inhibitor | / | Unkown | |
| HY-RI01678A | hsa-miR-548c-3p antagomir | / | Unkown | |
| HY-RI02506 | hsa-miR-892c-3p inhibitor | / | Unkown | |
| HY-RI02506A | hsa-miR-892c-3p antagomir | / | Unkown | |
| HY-RI02698 | mmu-miR-181c-3p inhibitor | / | Unkown | |
| HY-RI02698A | mmu-miR-181c-3p antagomir | / | Unkown | |
| HY-RI02795 | mmu-miR-1970c-3p inhibitor | / | Unkown | |
| HY-RI02795A | mmu-miR-1970c-3p antagomir | / | Unkown | |
| HY-RI02833 | mmu-miR-216c-3p inhibitor | / | Unkown | |
| HY-RI02833A | mmu-miR-216c-3p antagomir | / | Unkown | |
| HY-RI02840 | mmu-miR-219c-3p inhibitor | / | Unkown | |
| HY-RI02840A | mmu-miR-219c-3p antagomir | / | Unkown | |
| HY-RI02897 | mmu-miR-302c-3p inhibitor | / | Unkown | |
| HY-RI02897A | mmu-miR-302c-3p antagomir | / | Unkown | |
| HY-RI03043 | mmu-miR-344c-3p inhibitor | / | Unkown | |
| HY-RI03043A | mmu-miR-344c-3p antagomir | / | Unkown | |
| HY-RI03077 | mmu-miR-34c-3p inhibitor | / | Unkown | |
| HY-RI03077A | mmu-miR-34c-3p antagomir | / | Unkown | |
| HY-RI03104 | mmu-miR-374c-3p inhibitor | / | Unkown | |
| HY-RI03104A | mmu-miR-374c-3p antagomir | / | Unkown | |
| HY-RI03111 | mmu-miR-376c-3p inhibitor | / | Unkown | |
| HY-RI03111A | mmu-miR-376c-3p antagomir | / | Unkown | |
| HY-RI03148 | mmu-miR-449c-3p inhibitor | / | Unkown | |
| HY-RI03148A | mmu-miR-449c-3p antagomir | / | Unkown | |
| HY-RI03198 | mmu-miR-467c-3p inhibitor | / | Unkown | |
| HY-RI03198A | mmu-miR-467c-3p antagomir | / | Unkown | |
| HY-RI03460 | mmu-miR-669c-3p inhibitor | / | Unkown | |
| HY-RI03460A | mmu-miR-669c-3p antagomir | / | Unkown | |
| HY-RI04277 | rno-miR-196c-3p inhibitor | / | Unkown | |
| HY-RI04277A | rno-miR-196c-3p antagomir | / | Unkown | |
| HY-RI04284 | rno-miR-200c-3p inhibitor | / | Unkown | |
| HY-RI04284A | rno-miR-200c-3p antagomir | / | Unkown | |
| HY-RI04468 | rno-miR-449c-3p inhibitor | / | Unkown | |
| HY-RI04468A | rno-miR-449c-3p antagomir | / | Unkown | |
| HY-RI04484 | rno-miR-466c-3p inhibitor | / | Unkown | |
| HY-RI04484A | rno-miR-466c-3p antagomir | / | Unkown | |
| HY-RS00536 | AKR1C3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01744 | C3AR1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS05969 | H3C3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS05976 | H4C3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS10520 | PIK3C3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS10522 | Pik3c3 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W007798S | Fmoc-Cys(Trt)-OH-1,2,3-13C3,15N | 98.7% | Unkown | |
| HY-W007926S | 2-Oxobutanoic acid-13C,d2-1 | / | Unkown | |
| HY-W009204S4 | Fmoc-Ala-OH-13C3,15N | 99.9% | Unkown | |
| HY-W010407S2 | Cyanuric acid-13C3,15N3 | / | Unkown | |
| HY-W010575S | (2R)-3-Amino-2-fluoropropanoic acid-13C3 | / | Unkown | |
| HY-W010596S | Malonamide-13C3 | / | Unkown | |
| HY-W013061S11 | Tripalmitin (Glycerol 13C3,13C 99%) | / | Unkown | |
| HY-W013061S4 | Propane-1,2,3-triyl tripalmitate-13C3-1 | / | Unkown | |
| HY-W015084S | β-Ionone-13C3 | Inducer | / | Unkown |
| HY-W017529S | 6-Chloro-1,3,5-triazine-2,4-diamine-13C3 | / | Unkown | |
| HY-W017540S | Cyclocreatine-13C3 | / | Unkown | |
| HY-W018772S4 | D-Ribose-13C-3 | 99.9% | Unkown | |
| HY-W096151 | Chloroacetamido-C-PEG3-C3-NHBoc | / | Unkown | |
| HY-W127393 | N-Nonanoyl-L-homoserine lactone | / | Unkown | |
| HY-W127487 | N-Octadecanoyl-L-homoserine lactone | / | Unkown | |
| HY-W269693S | 5-(4-Hydroxyphenyl)-5-phenylimidazolidine-2,4-dione-13C3,d5 | / | Unkown | |
| HY-W324220 | 11β-HSD1-IN-10 | / | Unkown | |
| HY-W357090S | L-Idose-13C-3 | / | Unkown | |
| HY-W456457 | Tetrapyrido[3,2-a:2',3'-c:3'',2''-h:2''',3'''-j]phenazine | / | Unkown | |
| HY-W584535 | VH032-C3-Boc | / | Unkown | |
| HY-W585905 | Trimethylammonium chloride-13C3 | Inhibitor | / | Unkown |
| HY-W591717 | EM-12-alkyne-C3-NH2 | / | Unkown | |
| HY-W653931 | rac 1,2-Bis-palmitoyl-3-chloropropanediol-13C3 | / | Unkown | |
| HY-W653989 | Desonide-13C3 | / | Unkown | |
| HY-W654296 | Octocrylene-13C3 | / | Unkown | |
| HY-W706737 | N-Deschlorobenzoyl indomethacin-d3 | / | Unkown | |
| HY-W718035S | 1-Chloro-3-(octanoyloxy)propan-2-yl decanoate-13C3 | / | Unkown | |
| HY-W718041S | 1-Lauroyl-2-decanoyl-3-chloropropanediol-13C3 | / | Unkown | |
| HY-W747791 | 4,6-Dichloro-1,3,5-triazin-2-amine-13C3 | / | Unkown | |
| HY-W748430 | Furagin-13C3 | / | Unkown | |
| HY-W748519 | Sarcosine-13C3 | / | Unkown | |
| HY-W749145 | 2-Chloro-5-thiazolecarboxylic Acid-13C3,15N | / | Unkown | |
| HY-W749394 | 4-Methyl-5-thiazoleethanol-13C3 | / | Unkown | |
| HY-W749519 | (E,E)-Farnesol-13C3 | / | Unkown | |
| HY-W749742 | Isopropyltriphenylphosphonium bromide-13C3 | / | Unkown | |
| HY-W749783 | 1-Decanoyl-2-octanoyl-3-chloropropanediol-13C3 | / | Unkown | |
| HY-W749786 | 1-Decanoyl-2-lauroyl-3-chloropropanediol-13C3 | / | Unkown | |
| HY-W750553 | 2-Ethylhexyl 2-cyanoacetate-13C3 | / | Unkown | |
| HY-W751156 | O-Phospho-L-serine-13C3 | / | Unkown | |
| HY-W751753 | Ethyl (2-cyanoacetyl)carbamate-13C3,15N | / | Unkown | |
| HY-W751756 | 6-Cyano Diclazuril-13C3,15N2 | / | Unkown | |
| HY-W751808S | 2,3-Diphosphoglyceric acid-13C3 | / | Unkown | |
| HY-W751832 | 5,6-Diaminopyrimidine-2,4-diol hydrochloride-13C3 | / | Unkown | |
| HY-W751834 | 6-Amino-5-nitropyrimidine-2,4(1H,3H)-dione-13C3 | / | Unkown | |
| HY-W753497 | Benzene-1,2,4-tricarboxylic acid-13C3 | / | Unkown | |
| HY-W754236 | (R)-Carnitine Hydrochloride-13C3 | / | Unkown | |
| HY-W756586 | Rac 2-stearoyl-3-chloropropanediol-13C3 | / | Unkown | |
| HY-W756589 | Rac 2-linolenoyl-3-chloropropanediol-13C3 | / | Unkown | |
| HY-W759219 | Adrenosterone-13C3 | / | Unkown | |
| HY-W759459 | Meldrum's acid-13C3 | / | Unkown | |
| HY-W765177 | Acetyl-L-carnitine hydrochloride-13C3 | / | Unkown | |
| HY-W766603 | Thiouric Acid Sodium Salt Dihydrate-13C3 | / | Unkown | |
| HY-W768226 | D-Fructose-1,2,3-13C3 | / | Unkown | |
| HY-W768527 | Methyl piperidine-4-carboxylate hydrochloride-13C3 | / | Unkown | |
| HY-W768964 | a,a-Dimethyl-1H-indole-2-acetonitrile-13C315N | / | Unkown | |
| HY-W768990 | Vinclozolin-13C3,d3 | / | Unkown | |
| HY-W769556 | Ethyl Cyano(ethoxymethylene)acetate-13C3 | / | Unkown | |
| HY-W770279 | DL-Cytarabine-13C3 | / | Unkown | |
| HY-W770914 | Stearoyl-L-carnitine chloride-13C3 | / | Unkown | |
| HY-W776973 | Glycidamide-13C3 | / | Unkown | |
| HY-W777002 | Famotidine-13C3 | / | Unkown | |
| HY-W777084 | (E)-3,4-Dimethoxycinnamic acid-13C3 | / | Unkown | |
| HY-W777266 | Cyclohexane-1,3-dione-13C3 | / | Unkown | |
| HY-W777281 | Fluocinolone acetonide-13C3 | / | Unkown | |
| HY-W777340 | Gimeracil-13C3 | / | Unkown | |
| HY-W777351 | Etravirine-13C3 | / | Unkown | |
| HY-W777615 | Ammeline Hydrochloride-13C3 | / | Unkown | |
| HY-W777751 | 6-Desamino 6-chloro etravirine-13C3 | / | Unkown | |
| HY-W777806 | Pyrimido[1,2-a]purin-10(1H)-one-13C3 | / | Unkown | |
| HY-W777836 | 2,2-Dibromomalonamide-13C3 | / | Unkown | |
| HY-W777862 | 1-Stearoyl-rac-glycerol-13C3,d5 | / | Unkown | |
| HY-W778057 | Ethyl 3,4-Dihydroxybenzoate-13C3 | / | Unkown | |
| HY-W778286 | Enterolactone-13C3 | / | Unkown | |
| HY-W778288 | (±)-Enterodiol-13C3 | / | Unkown | |
| HY-W778511 | Levulinic acid-13C3 | / | Unkown | |
| HY-W778954 | 2,2-Dimethyl-1,3-dioxolane-4-methanol-13C3 | / | Unkown | |
| HY-W779236 | Ethyl Propargylate-13C3 | / | Unkown | |
| HY-W946627 | (S,R,S)-AHPC-Me-amide-C-O-C3-PEG1-NH2 | / | Unkown | |
| HY-Y0418S3 | Dulcite-13C-3 | / | Unkown | |
| HY-Y0504S | Trimethylammonium chloride-13c3,d9 | Inhibitor | 98% | Unkown |
| HY-Y0659S1 | 1,2,3,4-Hydroquinoline-13C3,15N | / | Unkown | |
| HY-Y0921S3 | (±)-1,2-Propanediol-13C3 | / | Unkown | |
| HY-Y1117S1 | Melamine-13C3 | 98.71% | Unkown | |
| HY-10002S | Calcitriol-13C3 | Inhibitor | 97.0% | Unkown |
| HY-100840 | (S)-4C3HPG | / | Unkown | |
| HY-100840A | (RS)-4C3HPG | Antagonist | / | Unkown |
| HY-112251S | D-Lin-MC3-DMA-13C3 | / | Unkown | |
| HY-115767S | (±)-1,2-Diolein-13C3 | Activator | / | Unkown |
| HY-119051 | BR111 | / | Unkown | |
| HY-122585 | proMMP-9 inhibitor-3c | Inhibitor | / | Unkown |
| HY-124432 | CRT0093964 | Inhibitor | / | Unkown |
| HY-125485 | Fmoc-C-PEG3-C3-Succinamic acid | / | Unkown | |
| HY-127035S1 | Tristearin-13C3 | / | Unkown | |
| HY-137225 | HTS07944 | / | Unkown | |
| HY-139227 | Thalidomide 4'-oxyacetamide-C1-PEG3-C3-amine hydrochloride | Inducer | / | Unkown |
| HY-144344S | Benzyl(2R)-3-N,N-dibenzylamino-2-fluoropropanoate-13C3 | / | Unkown | |
| HY-148637 | Picoberin | Agonist | / | Unkown |
| HY-149749 | Methylthiomcresol-C3-COOH | / | Unkown | |
| HY-150532S | (Rac)-Vitamin B5,Calcium Salt Hydrate-13C3 15N | / | Unkown | |
| HY-154746S | 3-HPMA Potassium Salt-3-13C3,15N | / | Unkown | |
| HY-154814S | Monohydroxy-3-butenyl-mercapturic acid-13C3,15N sodium | / | Unkown | |
| HY-159145 | Lenalidomide-acetylene-C3-MsO | / | Unkown | |
| HY-161652 | Thalidomide-NH-C3-O-Ph(NO2)-methylester-O-pyrrolidine-2,5-dione | / | Unkown | |
| HY-161656 | PIP-C-3-Azaspiro[5.5]undecane-boc | / | Unkown | |
| HY-163267 | ZNL0325 | / | Unkown | |
| HY-163647 | Lenalidomide-COCH-PEG2-azido | / | Unkown | |
| HY-165686 | Benalaxyl metabolite M2-13C3 | / | Unkown | |
| HY-168192 | Thalidomide-NH-C4-amide-C3-Br | / | Unkown | |
| HY-168380 | Lipid C3 | / | Unkown | |
| HY-172223 | 3-Deazaguanosine | Inhibitor | / | Unkown |
| HY-172296 | Biotinamide-C3-PEG3-C-alkyne | / | Unkown | |
| HY-173103S | FYDPL(Ala-13C3,15N)GK TFA | / | Unkown | |
| HY-17469S | Gimeracil-13C3,15N | / | Unkown | |
| HY-175506 | RyRs activator 6 | / | Unkown | |
| HY-175948 | Lenalidomide-CO-C3-NH-alkynes | / | Unkown | |
| HY-176038 | MS1262-C3-amide-C10-amine | / | Unkown | |
| HY-176893 | Mm-C3-OSu | / | Unkown | |
| HY-177148B | (E/Z)-G256 dihydrochloride | Substrate | / | Unkown |
| HY-180767 | Azithromycin-amide-C3-amide-quinoxaline | Inhibitor | / | Unkown |
| HY-182222 | 5'-Amino-modifier C3-TFA | / | Unkown | |
| HY-184103 | ECDG | Inhibitor | / | Unkown |
| HY-186237 | Fuc(1→2)-Gal(3→1)(C3-amide-C5-biotin)-GalNAc | / | Unkown | |
| HY-41700S5 | D-Alanine-13C3 | / | Unkown | |
| HY-B0111RS | Drospirenone-13C3 | / | Unkown | |
| HY-B0399S2 | L-Carnitine-13C3 | / | Unkown | |
| HY-B0510S3 | Trimethoprim-13C3 | Inhibitor | / | Unkown |
| HY-D0205AS1 | Carbocisteine-13C3-1 | / | Unkown | |
| HY-N0001S2 | (-)-Epicatechin-13C3 | / | Unkown | |
| HY-N0092S4 | Inosine-13C3 | Agonist | / | Unkown |
| HY-N0230S5 | β-Alanine-13C | / | Unkown | |
| HY-N0368S1 | Linalool-13C3 | / | Unkown | |
| HY-N0803S1 | Myrcene-13C3 | Inhibitor | / | Unkown |
| HY-N1071 | Wilforol C | / | Unkown | |
| HY-N12816 | Glaucogenin C 3-O-α-L-cymaropyranosyl-(1→4)–β-D-digitoxopyranosyl-(1→4)-β-D-canaropyranoside | / | Unkown | |
| HY-N14052 | Arizonin C3 | Inhibitor | / | Unkown |
| HY-N14105 | Cinatrin C3 | Inhibitor | / | Unkown |
| HY-N14419 | Salfredin C3 | Inhibitor | / | Unkown |
| HY-N14460 | Pluracidomycin C3 | Inhibitor | / | Unkown |
| HY-N14691 | Platenomycin C3 | Inhibitor | / | Unkown |
| HY-N1849 | 3'-Methoxyrocaglamide | / | Unkown | |
| HY-N5181 | Parvodicin C3 | Inhibitor | / | Unkown |
| HY-N7091S1 | Atrazine-13C3,15N3 | / | Unkown | |
| HY-N7092S22 | D-Fructose-13C3 | / | Unkown | |
| HY-N7092S23 | D-Fructose-13C3-1 | / | Unkown | |
| HY-N9332 | Kalopanax saponin G | / | Unkown | |
| HY-N9522 | β-D-glucopyranosyl-[α-L-rhamnopyranosyl-(1→3)-βD-glucuronopyranosyl-(1→3)]-3β-hydroxyolean-12-ene28-oate | 99.95% | Unkown | |
| HY-P0058S | Pramlintide-(Ala-13C3,15N) | / | Unkown | |
| HY-P1624S | Teduglutide-Ala(13C3,15N) sodium | / | Unkown | |
| HY-P6696S | β-CL, Ala(13C3,15N) TFA | / | Unkown | |
| HY-R04628 | mmu-miR-200c-3p mimic | / | Unkown | |
| HY-RI04615 | mmu-miR-200c-3p inhibitor | / | Unkown | |
| HY-RS16401 | NT5C3A Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS16520 | C3 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS22951 | C3 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23044 | Akr1c3 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS27683 | Nt5c3a Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS28019 | C3ar1 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W007941S | Fmoc-Ser(tBu)-OH-13C3,15N | 99.5% | Unkown | |
| HY-W009204S5 | Fmoc-Ala-OH-13C3 | Modulator | 98.5% | Unkown |
| HY-W012578S1 | 2-Isopropyl-3-methoxypyrazine-13C3 | / | Unkown | |
| HY-W012932S | 2,4-Dimethylthiazole-13C3 | / | Unkown | |
| HY-W020044S | DL-alpha-Tocopherol-13C3 | Inhibitor | / | Unkown |
| HY-W021040S | Fludioxonil-13C3 | / | Unkown | |
| HY-W091039S | N-Acetyl-α-neuraminic acid-13C3 | / | Unkown | |
| HY-W1110947 | (S)-3-Phosphoglyceric acid-13C3 sodium | / | Unkown | |
| HY-W1113139 | H2N-PEG4-C3-OH | / | Unkown | |
| HY-W115358 | Piperazin-C3-OH dihydrochloride | / | Unkown | |
| HY-W128657S | 3-Chloro-2-hydroxypropanoic acid-13C3 | / | Unkown | |
| HY-W130878 | 4-Octylphenol | Activator | / | Unkown |
| HY-W156840S | OTNE-13C3 | / | Unkown | |
| HY-W190925 | APN-C3-biotin | / | Unkown | |
| HY-W339437 | NH2-C3-PEG2-NH2 | / | Unkown | |
| HY-W440913 | DSPE-PEG5000-Cy5 | / | Unkown | |
| HY-W585819S | 3-Chloropropane-1,2-diol dipalmitate-13C3 | / | Unkown | |
| HY-W653853 | Ritonavir-13C3 | / | Unkown | |
| HY-W654120 | Creatine-13C3 | / | Unkown | |
| HY-W654126 | Cytarabine-13C3 | / | Unkown | |
| HY-W654127 | Cytarabine-13C3 5'-monophosphate | / | Unkown | |
| HY-W654156 | Diclazuril-13C3,15N2 | Inhibitor | / | Unkown |
| HY-W654362 | (R)-2-Thioxothiazolidine-4-carboxylic acid-13C3 | / | Unkown | |
| HY-W743781 | N-Nitrosonornicotine-d4 | / | Unkown | |
| HY-W747639 | Glycidyl Stearate-13C3 | / | Unkown | |
| HY-W748200 | 3-Hydroxypropionic acid-13C3 sodium | / | Unkown | |
| HY-W749516 | Voglibose-13C3 | Inhibitor | / | Unkown |
| HY-W749756 | rac-1,2-Distearoyl-3-chloropropanediol-13C3 | / | Unkown | |
| HY-W751098 | Aldosterone-13C3 | / | Unkown | |
| HY-W751099 | Corticosterone-13C3 | / | Unkown | |
| HY-W767866 | N-Acetyl-S-(2-carboxyethyl)cysteine-13C3 dicyclohexylamine | / | Unkown | |
| HY-W769714 | Favipiravir-13C3 | Inhibitor | / | Unkown |
| HY-W770183 | Uric acid-13C3 | / | Unkown | |
| HY-W777148 | Anagrelide-13C3 | / | Unkown | |
| HY-W923498 | Boc-NH-C3-O-Propargyl | / | Unkown | |
| HY-W998285 | Pomalidomide-C3-alkyne | / | Unkown | |
| HY-W998298 | (S,R,S)-AHPC-C5-PEG3-C3 | / | Unkown | |
| HY-W998312 | Thalidomide-O-amido-C3-COOH TFA | / | Unkown | |
| HY-W998315 | (S,R,S)-AHPC-Me-CO-C3-COOH | / | Unkown | |
| HY-W998328 | Thalidomide-O-amido-C3-NH2 hydrochloride | / | Unkown | |
| HY-109506S10 | DPPC-13C3 | / | Unkown | |
| HY-P3252AS | Pegcetacoplan-13C3,15N TFA | / | Unkown |
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P990216 | Anti-Mouse IL-25 Antibody (2C3) | Inhibitor | 95.00% | Unkown |
| HY-P991706 | Nelvutamig | Inhibitor | 97.76% | Unkown |
| HY-P99905 | Efdamrofusp alfa | 99.89% | Unkown | |
| HY-P990955 | Ebribafusp alfa | Inhibitor | 96.40% | Unkown |
| HY-P992456 | SAR-443809 | Inhibitor | / | Unkown |
| HY-P991590 | 1D09C3 | / | Unkown | |
| HY-P991936 | Anti-CEACAM5/CEA/CD66e Antibody (16C3) | / | Unkown | |
| HY-P992470 | STT-5058 | Inhibitor | / | Unkown |